全文获取类型
收费全文 | 632篇 |
免费 | 35篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 20篇 |
妇产科学 | 10篇 |
基础医学 | 44篇 |
口腔科学 | 8篇 |
临床医学 | 36篇 |
内科学 | 95篇 |
皮肤病学 | 14篇 |
神经病学 | 29篇 |
特种医学 | 47篇 |
外科学 | 160篇 |
综合类 | 18篇 |
预防医学 | 42篇 |
眼科学 | 1篇 |
药学 | 52篇 |
中国医学 | 1篇 |
肿瘤学 | 96篇 |
出版年
2023年 | 2篇 |
2022年 | 4篇 |
2021年 | 9篇 |
2020年 | 8篇 |
2019年 | 14篇 |
2018年 | 9篇 |
2017年 | 8篇 |
2016年 | 15篇 |
2015年 | 16篇 |
2014年 | 19篇 |
2013年 | 29篇 |
2012年 | 28篇 |
2011年 | 36篇 |
2010年 | 32篇 |
2009年 | 18篇 |
2008年 | 38篇 |
2007年 | 24篇 |
2006年 | 24篇 |
2005年 | 16篇 |
2004年 | 33篇 |
2003年 | 21篇 |
2002年 | 23篇 |
2001年 | 24篇 |
2000年 | 13篇 |
1999年 | 19篇 |
1998年 | 13篇 |
1997年 | 10篇 |
1996年 | 19篇 |
1995年 | 12篇 |
1994年 | 13篇 |
1993年 | 6篇 |
1992年 | 15篇 |
1991年 | 12篇 |
1990年 | 6篇 |
1989年 | 6篇 |
1988年 | 8篇 |
1987年 | 7篇 |
1986年 | 11篇 |
1985年 | 7篇 |
1984年 | 5篇 |
1983年 | 5篇 |
1982年 | 2篇 |
1980年 | 4篇 |
1979年 | 7篇 |
1967年 | 2篇 |
1939年 | 2篇 |
1907年 | 1篇 |
1906年 | 2篇 |
1904年 | 1篇 |
1899年 | 1篇 |
排序方式: 共有674条查询结果,搜索用时 15 毫秒
91.
Valerie W Rusch 《Journal of clinical oncology》2005,23(33):8283-8285
92.
93.
94.
95.
J A Rusch 《The Dental laboratory》1966,14(10):389-392
96.
Gene expression profiling allows distinction between primary and metastatic squamous cell carcinomas in the lung 总被引:1,自引:0,他引:1
Talbot SG Estilo C Maghami E Sarkaria IS Pham DK O-charoenrat P Socci ND Ngai I Carlson D Ghossein R Viale A Park BJ Rusch VW Singh B 《Cancer research》2005,65(8):3063-3071
Lung neoplasms commonly develop in patients previously treated for head and neck carcinomas. The derivation of these tumors, either as new primary lung cancers or as metastatic head and neck cancers, is difficult to establish based on clinical or histopathologic criteria since both are squamous cell carcinomas and have identical features under light microscopy. However, this distinction has significant treatment and prognostic implications. Gene expression profiling was performed on a panel of 52 sequentially collected patients with either primary lung (n = 21) or primary head and neck (n = 31) carcinomas using the Affymetrix HG_U95Av2 high-density oligonucleotide microarray. Unsupervised hierarchical clustering with Ward linkage and the Pearson correlation metric was performed. To assess robustness, bootstrap resampling was performed with 1,000 iterations. A t test of the normalized values for each gene was used to determine the genes responsible for segregating head and neck from lung primary carcinomas, and those with the most differential expression were used for later analyses. In the absence of a large "test" set of tumors, we used a supervised leave-one-out cross-validation to test how well we could predict the tumor origin. Once a gene expression profile was established, 12 lung lesions taken from patients with previously treated head and neck cancers were similarly analyzed by gene expression profiling to determine their sites of origin. Unsupervised clustering analysis separated the study cohort into two distinct groups which reliably remained segregated with bootstrap resampling. Group 1 consisted of 30 tongue carcinomas. Group 2 consisted of 21 lung cancers and 1 tongue carcinoma. The clustering was not changed even when normal lung or tongue profiles were subtracted from the corresponding carcinomatous lesions, and a leave-one-out cross-validation showed a 98% correct prediction (see Supplementary Data 1). A minimum set of 500 genes required to distinguish these groups was established. Given the ability to segregate these lesions using molecular profiling, we analyzed the lung tumors of undetermined origin. All cases clearly clustered with either lung or tongue tumor subsets, strongly supporting our hypothesis that this technique could elucidate the tissue of origin of metastatic lesions. Although histologically similar, squamous cell carcinomas have distinct gene expression profiles based on their anatomic sites of origin. Accordingly, the application of gene expression profiling may be useful in identifying the derivation of lung nodules and consequently enhances treatment planning. 相似文献
97.
Gupta V Mychalczak B Krug L Flores R Bains M Rusch VW Rosenzweig KE 《International journal of radiation oncology, biology, physics》2005,63(4):1045-1052
PURPOSE: To evaluate pleurectomy/decortication (P/D) and adjuvant radiotherapy (RT) in the treatment of malignant pleural mesothelioma (MPM). METHODS AND MATERIALS: In a retrospective review, we included MPM patients treated with P/D and adjuvant RT at Memorial Sloan-Kettering Cancer Center from 1974 to 2003. When indicated, patients received intraoperative brachytherapy to residual tumor. RESULTS: All 123 patients received external beam RT (median dose, 42.5 Gy; range, 7.2-67.8 Gy) to the ipsilateral hemithorax postoperatively. Fifty-four patients underwent brachytherapy (matched peripheral dose, 160 Gy). The median and 2-year overall survival for all patients was 13.5 months (range, 1-199 months) and 23%, respectively. One-year actuarial local control for all patients was 42%. Multivariate analysis for overall survival revealed radiation dose <40 Gy (p = 0.001), nonepithelioid histology (p = 0.002), left-sided disease (p = 0.01), and the use of an implant (p = 0.02) to be unfavorable. Two patients (1.6%) died from Grade 5 toxicity within 1 month of treatment. CONCLUSIONS: Pleurectomy/decortication with adjuvant radiotherapy is not an effective treatment option for patients with MPM. Our results imply that residual disease cannot be eradicated with external RT with or without brachytherapy and that a more extensive surgery followed by external RT might be required to improve local control and overall survival. 相似文献
98.
99.
100.
L Moreno SK McMaster T Gatheral LK Bailey LS Harrington N Cartwright PCJ Armstrong TD Warner M Paul-Clark JA Mitchell 《British journal of pharmacology》2010,160(8):1997-2007